Oorsprong van het eerstegraads netwerk van Shay Weisbrich
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases
12
| Extinct | Biotechnology | 12 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Shay Weisbrich via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Applied Immune Sciences, Inc.
 Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Medical Specialties | Corporate Officer/Principal | |
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Treasurer Founder | |
| GILEAD SCIENCES, INC. | Biotechnology | Human Resources Officer Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| DAVITA INC. | Medical/Nursing Services | Compliance Officer | |
| AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
Heartport, Inc.
 Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Medical Specialties | Corporate Officer/Principal | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Chairman Director/Board Member | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Comptroller/Controller/Auditor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
The North Carolina Biotechnology Center
 The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Chairman Director/Board Member | |
| CURIS, INC. | Biotechnology | Director/Board Member General Counsel | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| Recardia Therapeutics, Inc. | Director/Board Member President | ||
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | Director/Board Member | |
American Society for Investigative Pathology
 American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | Biotechnology | Corporate Officer/Principal | |
| POZEN INC. | Pharmaceuticals: Major | Director/Board Member | |
| Lenoir-Rhyne University | College/University | Undergraduate Degree | |
HBM Biocapital Ltd.
 HBM Biocapital Ltd. Financial ConglomeratesFinance Part of HBM Partners AG, HBM Biocapital Ltd. is a Caymanian company that provides investment services. The company is based in George Town, Cayman Islands. | Financial Conglomerates | Corporate Officer/Principal | |
Hatteras Venture Partners
 Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Investor | |
Clinipace, Inc.
 Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Miscellaneous Commercial Services | Director/Board Member | |
Clinverse, Inc.
 Clinverse, Inc. Packaged SoftwareTechnology Services Clinverse, Inc. provides automated financial management technology solutions for clinical trials. The firm’s products include ClinPay, ClinDebit and ClinViz. The company was founded on July 10, 2008 by Stephen Ayala and Tim S. Immel and is headquartered in Durham, NC. | Packaged Software | Director/Board Member | |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | President | |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
Solu Therapeutics
 Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Pharmaceuticals: Major | Director/Board Member | |
| American Society for Virology | President |
Statistieken
Internationaal
| Verenigde Staten | 44 |
| Nederland | 2 |
| Canada | 2 |
| Kaaimaneilanden | 2 |
Sectoraal
| Health Technology | 25 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Finance | 5 |
| Health Services | 4 |
Operationeel
| Director/Board Member | 181 |
| Corporate Officer/Principal | 61 |
| Independent Dir/Board Member | 50 |
| Chairman | 22 |
| General Counsel | 19 |
Sterkste connecties
| Insiders | |
|---|---|
| Peter Hutt | 69 |
| Kenneth Lee | 40 |
| Louis Lange | 35 |
| Santo Costa | 28 |
| Dan Spiegelman | 24 |
| Thomas Shenk | 21 |
| Peter G. Milner | 18 |
| Joseph M. Davie | 17 |
| Giacomo di Nepi | 16 |
| Kenneth F. Boehm | 12 |
| Barbara McNeil | 11 |
| Christine Guertin | 10 |
| Thomas L. Gutshall | 10 |
| Brian Beeler | 9 |
| Karin Walker | 8 |
- Beurs
- Insiders
- Shay Weisbrich
- Bedrijfsconnecties
